Patrick Evans, previously Partner at Knight Frank, has joined Montreux Capital Management (UK) [Montreux] as Investment Director. The move sees the company further strengthen its team due to increased deal flow and broader expansion plans as it grows its asset base.

Patrick who previously spent 17 years at Knight Frank and has worked alongside Montreux on many deals in the past, will add a breadth of experience across the investment function of the business, as well as a strong network within the sector.

The move is coupled with several key hires recently made by the firm, notably Dr. Amlan Basu as Chief Medical Officer, Fay Hitchenor as Head of People and Terry Allen as Senior Analyst. All of whom bring substantial experience either working within healthcare specific functions under private equity ownership or working within private markets directly.

On his appointment, Patrick Evans stated: “It’s a tremendous privilege to be joining Montreux at such an important time for the business. The Fund’s strategy to expand and constantly improve standards across our portfolio companies is driven by a simple ambition; to help residents, their families and staff members thrive. As demand for healthcare services increases, it is more important than ever that innovative owners continue to invest in the sector.”

Oliver Harris, Founder/Managing Partner, Montreux Capital Management (UK) stated: “We have made several key hires over the past few months, maintaining our position as one of the best teams in UK specialist care investment. Patrick joining our team is great news for our investors and wider stakeholders as his expertise will add significantly to our acquisition process and his network ought to increase deal flow further”.

Find Us

Thameside House
Hurst Road
East Molesey

T: + 44 (0) 1932 860 140

Information on this webpage relates to and is provided by Montreux Capital Management (UK) Limited

The content of this webpage should not be construed as financial advice. Any decision to invest should be made only on the basis of the relevant documentation for each investment. Past performance is not necessarily a guide to future performance. The value of an investment may go down as well as up and investors may not get back the full amount invested. Investments in small unquoted companies carry an above-average level of risk. These investments are highly illiquid and as such, there may not be a readily available market to sell such an investment. Montreux Capital Management (UK) Limited and Sapia Partners LLP (together “the Sponsors,” or “Sponsor”) do not provide specific individual advice on the suitability of investments with regard to a potential investor’s individual circumstances, risk tolerance or investment objectives and investors should seek independent financial advice if they are in any doubt whether a product is suitable for them.

Montreux Capital Management (UK) Limited is an Appointed Representative of Sapia Partners LLP which is authorised and regulated by the Financial Conduct Authority.